Pharmacopeia
(Nasdaq: PCOP), an innovator in the discovery and development of novel
small molecule therapeutics, announced that results from the
company’s Phase 2a clinical trial evaluating PS433540, its first-in-class
Dual Acting Receptor Antagonist (DARA), will be presented as a
late-breaking clinical trial at the American Society of Hypertension (ASH)
Twenty-Third Annual Scientific Meeting and Exposition in New Orleans, May
14-17, 2008.
PS433540 is […]

Even when their blood pressure is kept strictly under control with the best available medicine, African-American patients with chronic kidney disease (CKD) continue to lose their kidney function over time, research led by a Johns Hopkins team shows. The finding suggests that treating CKD in this population may be vastly more complex than researchers had […]

A research project at the University of Leicester in conjunction with the University of East Anglia, indicates that early reduction of high blood pressure following stroke is feasible and safe, and both Labetalol & Lisinopril were found to be suitable a medications for this purpose.
Larger studies will now be necessary to confirm this result and […]

Latest News For This Category
Correlation Between Erectile Dysfunction And LUTS The AUA Lecture
19 Apr 2008
A Mixed Set Of Results From 5-Alpha-Reductase Inhibitors And Reduced Prostate Cancer Risk
16 Apr 2008
Federal Authorities Seize More Than 100,000 Dollars Of Unapproved Drugs Marketed As "Natural Supplements"
10 Apr 2008
View more news…
Latest Videos for Erectile Dysfunction
Penile Pump Expectations
For many men suffering […]

Perrigo Company
(Nasdaq: PRGO; TASE) announced that it has received final approval
from the U.S. Food and Drug Administration to manufacture and market
over-the-counter (OTC) Children’s Cetirizine Hydrochloride Oral Solution
(Allergy) and Children’s Cetirizine Hydrochloride Oral Solution
(Hives-Relief), 1mg/mL.
The product will be marketed under store brand labels and is comparable
to McNeil Consumer Healthcare’s Children’s Zyrtec(R) Oral Solution, 1mg/mL,
indicated for indoor […]